PRVA (Privia Health Group, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by PRVA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Opella Finley Ernest | Director | A | — | — |
| 2026-07-13 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-07-09 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-07-07 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-07-07 | Matthew Shawn Morris | Director | MIXED | — | — |
| 2026-07-02 | Matthew Shawn Morris | Director | MIXED | — | — |
| 2026-05-22 | Jaewon Ryu | Director | A | — | — |
| 2026-05-22 | NANCY G COCOZZA | Director | A | — | — |
| 2026-05-22 | LANCE BERBERIAN | Director | A | — | — |
| 2026-05-22 | Thomas A McCarthy | Director | A | — | — |
| 2026-05-22 | DAVID P KING | Director | A | — | — |
| 2026-05-22 | FRANCIS S SOISTMAN JR | Director | A | — | — |
| 2026-05-22 | Matthew Shawn Morris | Director | A | — | — |
| 2026-05-22 | Pamela O Kimmet | Director | A | — | — |
| 2026-05-13 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2026-05-13 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-05-05 | Matthew Shawn Morris | Director | MIXED | — | — |
| 2026-05-05 | David Mountcastle | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-04-06 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-03-18 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-03-18 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2026-03-16 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2026-03-16 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-03-12 | David Mountcastle | EVP & Chief Financial Officer | A | — | — |
| 2026-03-12 | Parth Mehrotra | Chief Executive Officer | MIXED | — | — |
| 2026-03-12 | Edward C Fargis | EVP & General Counsel | A | — | — |
| 2026-03-10 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2026-03-10 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2026-03-10 | Edward C Fargis | EVP & General Counsel | Sell | — | — |
| 2026-03-02 | Matthew Shawn Morris | Director | MIXED | — | — |
| 2026-03-02 | David Mountcastle | EVP & Chief Financial Officer | MIXED | — | — |
| 2025-12-16 | Matthew Shawn Morris | Director | MIXED | — | — |
| 2025-12-16 | David Mountcastle | EVP & Chief Financial Officer | MIXED | — | — |
| 2025-07-17 | LANCE BERBERIAN | Director | A | — | — |
| 2025-05-23 | NANCY G COCOZZA | Director | A | — | — |
| 2025-05-23 | Jaewon Ryu | Director | A | — | — |
| 2025-05-23 | Patricia Anne Maryland | Director | A | — | — |
| 2025-05-23 | DAVID P KING | Director | A | — | — |
| 2025-05-23 | Thomas A McCarthy | Director | A | — | — |
| 2025-05-23 | DAVID S WICHMANN | Director | A | — | — |
| 2025-05-23 | Matthew Shawn Morris | Director | A | — | — |
| 2025-05-23 | Pamela O Kimmet | Director | A | — | — |
| 2025-05-14 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2025-05-14 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2025-05-02 | Matthew Shawn Morris | Director | Sell | — | — |
| 2025-05-02 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2025-05-02 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2025-04-03 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| 2025-03-14 | Parth Mehrotra | Chief Executive Officer | Sell | — | — |
| 2025-03-12 | David Mountcastle | EVP & Chief Financial Officer | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 28,676,936 | — |
| — | 10%+ Owner | 24,826,071 | — |
| — | 10%+ Owner | 20,019,808 | — |
| — | 10%+ Owner | 17,741,723 | — |
| — | 10%+ Owner | 15,215,054 | — |
| — | Director | 5,773,522 | — |
| — | Director | 5,478,934 | — |
| — | Director | 3,599,589 | — |
| — | Director | 1,341,049 | — |
| — | Chief Executive Officer | 583,475 | — |
| — | EVP & Chief Financial Officer | 173,548 | — |
| — | Director | 142,860 | — |
| — | EVP & General Counsel | 111,979 | — |
| — | Director | 110,337 | — |
| — | 10%+ Owner | 110,337 | — |
| — | 10%+ Owner | 110,337 | — |
| — | EVP, General Counsel | 102,356 | — |
| — | Director | 69,470 | — |
| — | EVP, CFO and CAO | 61,307 | — |
| — | Director | 50,775 | — |
| — | Director | 47,110 | — |
| — | Director | 42,814 | — |
| — | Director | 42,312 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PRVA quote page; the site-wide leaderboard is on the insider transactions hub.